(IBDX) iShares Trust - iShares - Ratings and Ratios
Corporate Bonds, Fixed-Income, Index Tracker
Dividends
| Dividend Yield | 4.80% |
| Yield on Cost 5y | 5.77% |
| Yield CAGR 5y | 46.30% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 3.29% |
| Value at Risk 5%th | 5.56% |
| Relative Tail Risk | 2.62% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.68 |
| Alpha | 3.74 |
| CAGR/Max DD | 0.77 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.508 |
| Beta | 0.092 |
| Beta Downside | 0.062 |
| Drawdowns 3y | |
|---|---|
| Max DD | 8.10% |
| Mean DD | 1.79% |
| Median DD | 1.55% |
Description: IBDX iShares Trust - iShares November 16, 2025
The iShares iBonds Dec 2032 Term Corporate ETF (NYSE ARCA: IBDX) seeks to track its benchmark by holding at least 80% of its assets in the index’s component securities and a minimum of 90% in fixed-income instruments that match the index’s composition, including non-U.S. corporate issuers when required for tracking fidelity.
Key metrics as of the latest reporting period: a weighted-average yield of roughly 4.3%, a modified duration near 8.5 years, and an average credit rating of “BBB-” (S&P), indicating exposure primarily to investment-grade corporates in Europe and Asia. The fund’s performance is sensitive to the Eurozone’s monetary-policy trajectory and corporate earnings trends in the industrial and technology sectors, which together drive credit spreads and default risk.
For a deeper, data-driven analysis of how IBDX’s risk-return profile fits your portfolio, you may find the ValueRay platform’s interactive dashboards useful for further investigation.
What is the price of IBDX shares?
Over the past week, the price has changed by +1.10%, over one month by +0.16%, over three months by +2.52% and over the past year by +8.16%.
Is IBDX a buy, sell or hold?
What are the forecasts/targets for the IBDX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 28.8 | 11.7% |
IBDX Fundamental Data Overview November 19, 2025
Beta = 1.23
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.36b USD (1.36b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.36b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.36b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.36% (E(1.36b)/V(1.36b) * Re(6.36%) + (debt-free company))
Discount Rate = 6.36% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBDX ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle